Gerben Schaaf

Dr. Gerben Schaaf is an Assistant Professor in the Department of Pediatrics at Erasmus University Medical Center in Rotterdam, Netherlands. His research focuses on rare genetic disorders, particularly lysosomal storage diseases and congenital malformations.

Dr. Schaaf's primary research interests center around gene therapy approaches for Mucopolysaccharidosis II (Hunter Syndrome) and Pompe disease. His work investigates lentiviral gene therapy techniques using tagged Iduronate-2-Sulfatase to address life-threatening pathologies in peripheral tissues and neurological complications. Additionally, he has research interests in congenital diaphragmatic hernia, exploring cellular origins and developmental mechanisms, as well as studies on the enteric nervous system and its role in gastrointestinal disorders.

Analysis of Dr. Schaaf's publication record reveals a strong focus on translational research bridging basic science and clinical applications. His work spans multiple disciplines including molecular genetics, cell biology, and pediatric medicine, with particular emphasis on developing therapeutic interventions for rare genetic disorders. The research demonstrates progression from fundamental cellular mechanisms to preclinical therapeutic applications.

Dr. Schaaf has supervised at least one research project as indicated by the 'Supervised Work (1)' mention in his profile. His collaborative network includes researchers across various departments at Erasmus MC, with frequent co-authorship with colleagues specializing in gene therapy, metabolic disorders, and developmental biology. His work has attracted attention across social media platforms and academic networks as evidenced by mentions on X (Twitter) and readership on Mendeley.